We elected to calculate the estimated prevalence of TRAPS in France, basing our calculations on patients who displayed likely pathogenic or pathogenic variants in TNFRSF1A, in accordance with the European recommendations [16]. The gene discussed is TNFRSF1A; the disease is TNF receptor 1-associated periodic fever syndrome.